Filing Details
- Accession Number:
- 0001140859-22-000109
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-14 16:52:41
- Reporting Period:
- 2022-12-12
- Accepted Time:
- 2022-12-14 16:52:41
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1140859 | Amerisourcebergen Corp | ABC | Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122) | 233079390 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1191508 | H Steven Collis | 1 West First Avenue Conshohocken PA 19428 | Chairman, President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2022-12-12 | 3,534 | $0.00 | 290,967 | No | 5 | G | Direct | |
Common Stock | Disposition | 2022-12-12 | 33,000 | $166.01 | 257,967 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2022-12-12 | 1,262 | $0.00 | 259,229 | No | 4 | M | Direct | |
Common Stock | Disposition | 2022-12-12 | 1,262 | $167.20 | 257,967 | No | 4 | F | Direct | |
Common Stock | Acquisiton | 2022-12-13 | 45,920 | $75.61 | 303,887 | No | 4 | M | Direct | |
Common Stock | Disposition | 2022-12-13 | 38,218 | $165.45 | 265,669 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-12-13 | 6,782 | $166.28 | 258,887 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-12-13 | 920 | $167.92 | 257,967 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 5 | G | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Restricted Stock Units | Disposition | 2022-12-12 | 1,262 | $0.00 | 1,262 | $0.00 |
Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2022-12-13 | 45,920 | $0.00 | 45,920 | $75.61 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
30,346 | No | 4 | M | Direct | ||
0 | 2023-11-09 | No | 4 | M | Direct |
Footnotes
- The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $165.63 to $166.52, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
- Restricted stock units received on 11/9/2022 for no consideration that vest in three equal annual installments on 11/9/2023, 11/9/2024, and 11/9/2025.
- Reflects partial lapsing of restrictions on installment scheduled to vest on 11/9/2023 to cover FICA obligation and associated income taxes for retirement eligible employees on 2022 grant of restricted stock units.
- The closing price of the Company's common stock on 12/12/22, the date used to calculate the FICA tax obligation in accordance with IRS rules.
- The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $165.00 to $165.98, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
- The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $166.03 to $166.63, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
- Exercisable in four equal annual installments on 11/9/2017, 11/9/2018, 11/9/2019 and 11/9/2020.